23Andme Holding Co. (ME)

$0.96 0.12 (10.82%)

16:00 EDT ME Stock Quote Delayed 30 Minutes

3 Gene Testing Stocks to Buy Before They Take Off

By John Blankenhorn, InvestorPlace Contributor Jun 17, 2023

The future of gene testing is bright thanks to an aging population. Here are three companies leading the industry.

Hero or Zero? 3 High-Risk Penny Stocks to Make You Rich … or Broke.

25 Meme Stocks to Sell Before They Die

CFO Transition Rocks 23andMe (ME) Stock

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 3.43M

Day's Range $0.96 - $1.05

52-Week Range $0.96 - $3.50

Dividend & Yield N/A (N/A)

ME Stock Predictions, Articles, and 23Andme Holding Co. News

From InvestorPlace
From the Web

What Is Going on With 23andMe (ME) Stock Today?

By Bret Kenwell, InvestorPlace Contributor Aug 11, 2022

23andMe, Invitae and others are seeing an explosive rally, but investors want to know if ME stock and others can continue to climb.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Jul 28, 2022

Good morning! It's time for another dive into the biggest pre-market stock movers as we check out what's happening Thursday morning!

7 Undervalued Reddit Stocks to Buy Before Wall Street Catches On

By Faizan Farooque, InvestorPlace Contributor Jul 1, 2022

Reddit is one of the most popular sites on the internet, meaning Reddit stocks like TLRY, AAPL, and WBD are companies you cannot ignore.

7 Badly Bruised Stocks to Buy for the Tough-as-Nails Contrarian

By Josh Enomoto, InvestorPlace Contributor Feb 11, 2022

Although the market is full of potential pitfalls, risk-tolerant contrarians could consider these discounted stocks to buy.

ME Stock: 6 Things to Know About 23andMe as Shares Shoot Higher Today

By William White, InvestorPlace Writer Oct 15, 2021

23andMe (ME) stock is running higher on Friday as investors pile on with heavy trading thanks to a recent interview on CNBC.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Oct 15, 2021

Good morning! It's the final day of the week and we're starting the end with a look at the biggest pre-market stock movers for Friday!

7 SPACs to Buy That Are Better Than Bill Ackman’s Pershing Square Tontine

By Thomas Niel, InvestorPlace Contributor Sep 15, 2021

The billionaire's blank-check company proved to be a bust, but these seven other SPACs still have a shot at becoming long-term winners.

ME Stock: The Credit Suisse Call Giving 23andMe a Boost Today

By William White, InvestorPlace Writer Aug 17, 2021

23andMe (ME) stock is rising higher on Tuesday after Credit Suisse weighed in on the personal genomics and biotechnology company.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Jun 30, 2021

Good morning! We're taking a look at the biggest pre-market stock movers for Wednesday and that includes the winners and losers.

ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut

By William White, InvestorPlace Writer Jun 18, 2021

23andMe (ME) stock is on the move Friday after the genetics company made its public debut on the Nasdaq Exchange yesterday.

23andMe chief administrative officer acquires, sells shares (NASDAQ:ME)

From Seeking Alpha Sep 26, 2023

Consumer genetics testing company 23andMe's chief administrative officer acquired and sold shares at double the price, with the stock currently trading at $0.99.

23andME (NASDAQ:ME) Rises on FDA Approval to Report Additional BRCA Gene Variants

From TipRanks Sep 1, 2023

23andMe (NASDAQ:ME) shares are on the rise today after the genetics and biopharmaceutical company bagged a 510(k) clearance from the U.S. Food and Drug Administrati...

Better AI Biotech Stock: Recursion Pharmaceuticals vs. 23andMe

From The Motley Fool Aug 25, 2023

Both businesses have a lot to prove.

Why 23andMe Holding Stock Plummeted by 13% Today

From The Motley Fool Aug 9, 2023

Investors reacted sharply and not well to the company's inaugural set of fiscal 2024 earnings.

23andMe down 3% on Q1 earnings, guidance revision (NASDAQ:ME)

From Seeking Alpha Aug 8, 2023

23andMe (ME) is down 3% in post-market trading Tuesday after it changed its fiscal 2024 net loss and EBITDA projections for fiscal 2024. Read more here.

23andMe GAAP EPS of -$0.23 misses by $0.04, revenue of $60.86M beats by $3.96M (NASDAQ:ME)

From Seeking Alpha Aug 8, 2023

23andMe press release (ME): Q1 GAAP EPS of -$0.23 misses by $0.04.Revenue of $60.86M (-5.6% Y/Y) beats by $3.96M.Revenue guidance for FY2024, which will end on March 31, 2024,...

23Andme Holding Co. (ME)

3 Gene Testing Stocks to Buy Before They Take Off

Hero or Zero? 3 High-Risk Penny Stocks to Make You Rich … or Broke.

25 Meme Stocks to Sell Before They Die

CFO Transition Rocks 23andMe (ME) Stock

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

23Andme Holding Co. (ME)

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

ME Stock Predictions, Articles, and 23Andme Holding Co. News

Subscriber Sign in